Skip to main content

Tobacco Use

0
Pipeline Programs
6
Companies
12
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
3 programs
Click City®: TobaccoN/A1 trial
Referral to QuitlineN/A1 trial
Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation TipsN/A1 trial
Active Trials
NCT03682900Completed2,673Est. Jun 2022
NCT05612152Unknown1,600Est. Jul 2024
NCT05797155Completed437Est. Mar 2025
Century Therapeutics
Century TherapeuticsPHILADELPHIA, PA
3 programs
Non-Menthol Very Low Nicotine CigarettesN/A1 trial
VLN cigarettesPHASE_11 trial
VLN menthol cigarettesPHASE_11 trial
Active Trials
NCT03571724Completed142Est. Mar 2019
NCT03559751Completed66Est. Sep 2018
NCT03559725Completed55Est. Oct 2018
Jasper Therapeutics
Jasper TherapeuticsREDWOOD CITY, CA
1 program
Approach Avoidance TrainingN/A1 trial
Active Trials
NCT02481752Completed52Est. Mar 2016
Pfizer
PfizerNEW YORK, NY
1 program
TrainingN/A2 trials
Active Trials
NCT03556774Unknown2,200Est. Aug 2021
NCT01748786Completed94Est. Jul 2012
Alliance Pharmaceuticals
1 program
TrainingN/A2 trials
Active Trials
NCT07716462Not Yet Recruiting20Est. Dec 2027
NCT03040349Unknown300Est. Dec 2019
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
varies by projectN/A1 trial
Active Trials
NCT01323023Completed4,463Est. Jan 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Century TherapeuticsVLN menthol cigarettes
Century TherapeuticsVLN cigarettes
Alliance PharmaceuticalsTraining
Oregon TherapeuticsSupport2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips
Oregon TherapeuticsReferral to Quitline
Oregon TherapeuticsClick City®: Tobacco
PfizerTraining
Century TherapeuticsNon-Menthol Very Low Nicotine Cigarettes
Alliance PharmaceuticalsTraining
Jasper TherapeuticsApproach Avoidance Training
PfizerTraining
Colorado Therapeuticsvaries by project

Clinical Trials (12)

Total enrollment: 12,102 patients across 12 trials

NCT03559725Century TherapeuticsVLN menthol cigarettes

Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes

Start: May 2018Est. completion: Oct 201855 patients
Phase 1Completed
NCT03559751Century TherapeuticsVLN cigarettes

Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes

Start: Apr 2018Est. completion: Sep 201866 patients
Phase 1Completed
NCT07716462Alliance PharmaceuticalsTraining

Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus

Start: Oct 2026Est. completion: Dec 202720 patients
N/ANot Yet Recruiting
NCT05797155Oregon TherapeuticsSupport2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips

A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation

Start: Dec 2023Est. completion: Mar 2025437 patients
N/ACompleted
NCT05612152Oregon TherapeuticsReferral to Quitline

Choose2Quit: Improving Equity in Smoking Cessation for Low Income Adults

Start: Nov 2022Est. completion: Jul 20241,600 patients
N/AUnknown
NCT03682900Oregon TherapeuticsClick City®: Tobacco

Expanding the Click City Tobacco Prevention Program to Include E-cigarettes and Other Novel Tobacco Products

Start: Oct 2019Est. completion: Jun 20222,673 patients
N/ACompleted
NCT03556774PfizerTraining

Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

Start: Apr 2019Est. completion: Aug 20212,200 patients
N/AUnknown
NCT03571724Century TherapeuticsNon-Menthol Very Low Nicotine Cigarettes

A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes

Start: Jun 2018Est. completion: Mar 2019142 patients
N/ACompleted
NCT03040349Alliance PharmaceuticalsTraining

Tobacco Treatment TrAining Network in Greece & Cyprus

Start: Feb 2017Est. completion: Dec 2019300 patients
N/AUnknown
NCT02481752Jasper TherapeuticsApproach Avoidance Training

The Effect of AAT Training in Smokers

Start: Jul 2015Est. completion: Mar 201652 patients
N/ACompleted
NCT01748786PfizerTraining

Online Mindfulness Training Versus Health Education for Fibromyalgia

Start: Jan 2011Est. completion: Jul 201294 patients
N/ACompleted
NCT01323023Colorado Therapeuticsvaries by project

A Study to Examine Health Behavior Change Strategies for Primary Care

Start: Jun 2005Est. completion: Jan 20134,463 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.